Tech Company M&A Transactions

Allegro Diagnostics Acquisition

Allegro Diagnostics, based in Maynard, was acquired by Veracyte. Veracyte said the transaction price was $21 million.

Transaction Overview

Acquired By
Announced On
9/5/2014
Transaction Type
M&A
Amount
$21,000,000
M&A Terms
The purchase price is comprised of $7.8 million in cash and $13.2 million in Veracyte common stock.

Company Information

Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
6 Clock Tower Pl. 225
Maynard, MA 01754
USA
Email Address
Overview
Allegro Diagnostics is a leader in the field of gene expression molecular diagnostic testing for lung cancer and other diseases.
Profile
Allegro Diagnostics LinkedIn Company Profile
Social Media
Allegro Diagnostics Company Twitter Account
Company News
Allegro Diagnostics News
Facebook
Allegro Diagnostics on Facebook
YouTube
Allegro Diagnostics on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Michael Webb
  Michael Webb LinkedIn Profile  Michael Webb Twitter Account  Michael Webb News  Michael Webb on Facebook
Chief Financial Officer
Bill Johnson
  Bill Johnson LinkedIn Profile  Bill Johnson Twitter Account  Bill Johnson News  Bill Johnson on Facebook
VP - R & D
Duncan Whitney
  Duncan Whitney LinkedIn Profile  Duncan Whitney Twitter Account  Duncan Whitney News  Duncan Whitney on Facebook


 

 

Browse more venture capital transactions:

Prev: 9/5/2014: Flywheel venture capital transaction
Next: 9/5/2014: HoneyComb Drone venture capital transaction

 

Share this article

 


Where The Data Comes From

We do our best to report on every notable VC transaction. VC investment data records on this site are sourced from a variety of public sources. The data is sourced from VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary